Patents-Review.com
ClassID:

170540 ⎘

G01N2333/8132 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors; Serpins Plasminogen activator inhibitors

Recent Application in this class:
#1
20250305057
2025-10-02

BLADDER CANCER BIOMARKERS AND METHODS OF USE

 #2
20250146075
2025-05-08

METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS

 #3
20230313305
2023-10-05

METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS

 #4
20220170944
2022-06-02

MATERIALS AND METHODS FOR IDENTIFYING AND TREATING EOSINOPHILIC DISORDERS

 #5
20220057410
2022-02-24

Biomarkers of vascular disease

 #6
20200165677
2020-05-28

METHODS AND USES OF INFLAMMATORY BOWEL DISEASE BIOMARKERS

 #7
20190339278
2019-11-07

Cell response assay for cancer and methods of producing and using same

 #8
20190137508
2019-05-09

System and method for determining risk of diabetes based on biochemical marker analysis

 #9
20180364257
2018-12-20

Biomarkers of vascular disease

 #10
20180156815
2018-06-07

SYSTEM AND METHOD FOR DETERMINING RISK OF DIABETES BASED ON BIOCHEMICAL MARKER ANALYSIS

 #11
20170153241
2017-06-01

CELL RESPONSE ASSAY FOR CANCER AND METHODS OF PRODUCING AND USING SAME

 #12
20160161504
2016-06-09

METHOD FOR PREDICTING TREATMENT RESPONSE AND TEST FOR SAFE USE OF MESENCHYMAL STEM CELLS ON INFLAMMATORY DISEASES

 #13
20160146818
2016-05-26

Bladder cancer detection composition, kit, and associated methods

 #14
20160025739
2016-01-28

Pre-eclampsia biomarkers

 #15
20140343321
2014-11-20

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

 #16
20140315227
2014-10-23

Therapeutic agent for preterm delivery or abortion using plasminogen activator inhibitor-1

 #17
20140273024
2014-09-18

System and method for determining risk of diabetes based on biochemical marker analysis

 #18
20120220524
2012-08-30

ASSAYS FOR CANCER PATIENT MONITORING BASED ON LEVELS OF ANALYTE COMPONENTS OF THE PLASMINOGEN ACTIVATOR SYSTEM IN BODY FLUID SAMPLES

 #19
20110300564
2011-12-08

Kit for prediction of pre-eclampsia

 #20
20100254979
2010-10-07

Humanized PAI-1 Antibodies and Uses Thereof

 #21
20090286268
2009-11-19

Assays for Cancer Patient Monitoring Based on Levels of Analyte Components of the Plasminogen Activator System in Body Fluid Samples

 #22
20090011429
2009-01-08

Kit for diagnosis of pre-eclampsia

 #23
20090011055
2009-01-08

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

 #24
20090004679
2009-01-01

METHOD FOR DETERMINING PLASMINOGEN ACTIVATOR INHIBITOR

 #25
20080113392
2008-05-15

Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples

 #26
20050037956
2005-02-17

Screening method for agents useful in treating diabetes